Daniel van den Bergh
Senior Investment Director @ Endeavour Vision
San Francisco Bay Area, United States
Daniel van den Bergh is a Series B investor at Endeavour Vision in San Francisco Bay Area focused on Health Care and Software. Daniel van den Bergh is the Senior Investment Director at Endeavour Vision. Daniel van den Bergh attended at University of Pennsylvania - The Wharton School.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Daniel van den Bergh invests in
Stages Daniel van den Bergh invests in
Countries Daniel van den Bergh invests in
Investment Focus
Industry
- Health Care 2 (67%)
- Software 1 (33%)
- Wellness 1 (33%)
- InsurTech 1 (33%)
- Therapeutics 1 (33%)
Stage
- Series B 2 (67%)
- Series A 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
SureCo
|
Rebuilding American Health Care through ICHRA | $23M / Series A / Sep 30, 2025 | |
NOCD
|
NOCD is an online OCD therapy platform that helps people with OCD get better and then stay better. With NOCD, users can have face-to-face video therapy sessions with licensed therapists that specialize in OCD, as well as get 24/7 support between sessions from self-help tools and peer communities. | $33M / Series B / Sep 21, 2021 | |
Ordr
|
Ordr makes it easy to secure every connected device, from traditional IT devices to newer and more vulnerable IoT, IoMT, and OT. Ordr uses deep packet inspection and advanced machine learning to discover every device, profile its risk and behavior, map all communications and protect it with automated policies. Organizations worldwide trust Ordr toprovide real-time asset inventory, address risk and compliance and accelerate IT initiatives. Ordr is backed by top investors including Battery Ventures, Wing, and TenEleven Ventures. | $6M / Series B / Mar 05, 2020 |
Co-Investors
About Endeavour Vision
Endeavour Vision is a private equity firm investing in growth-stage MedTech and digital health companies. The company invests in medical innovation that provides superior clinical benefits for patients or brings significant efficiencies to health systems. Endeavour Vision team offers strategic and operational expertise and extensive internationalexperience investing in companies in Europe and North America. We have a proven track record of successful exits with recently realized investments that include Vertiflex (acquired by Boston Scientific in 2019), Medartis (IPO on SIX in Q1 2018), and Symetis (acquired by Boston Scientific in 2017). Endeavour Vision’s offices are located in Geneva, Switzerland, and Minneapolis, U.S.
Endeavour Vision Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alex Schmitz
Partner
|
|||
Bernard Vogel
Founder and Managing Partner
|
|||
Damien Tappy
President & Managing Partner
|
|||
|
Daniel van den Bergh
Senior Investment Director
|
|||
Fernando Pacheco
Investment Director
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Daniel van den Bergh invest in?
Daniel van den Bergh invests primarily in Health Care, Software and Wellness startups, most often at Series B and Series A stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Daniel van den Bergh last invest?
The most recent investment recorded for Daniel van den Bergh closed in Sep 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
